Search all trials

Find therapies in clinical trials near you – page 27

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hepatic cirrhosis

Not recruiting

Registered drugNo placebo

Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Human Serum Albumin

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Imatinib

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Investigational

Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Rosnilimab

Contact Research Centre

Metabolic dysfunction-associated liver disease

Not recruiting

Investigational

Study on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)

Investigational

Belgium

Participants:18–64 years
Substances:Gsk4532990A

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Imatinib

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Registered drugNo placebo

Study on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years
Substances:Everolimus

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drug

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

K-ras gene mutation+1

Not recruiting

InvestigationalNo placebo

Study of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Breast cancer

Not recruiting

Registered drug

Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Alopecia areata

Not recruiting

Investigational

Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

Investigational

Belgium

Participants:0–17 years · 18–64 years
Substances:Upadacitinib

Contact Research Centre

Renal cell carcinoma

Not recruiting

Registered drugNo placebo

Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Find therapies in clinical trials near you – page 27

433 trials match your criteria

Hepatic cirrhosis

Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

Hepatocellular carcinoma

Study of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment

Pulmonary arterial hypertension

Study on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)

Rheumatoid arthritis

Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

Metabolic dysfunction-associated liver disease

Study on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)

Pulmonary arterial hypertension

Long-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension

Gastroenteropancreatic neuroendocrine tumour disease

Study on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment

Hormone receptor positive HER2 negative breast cancer

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

K-ras gene mutation+1

Study of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer

Breast cancer

Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

Alopecia areata

Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

Renal cell carcinoma

Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.